4D Molecular Therapeutics tumbles 21% in 2024, underperforming 87% of its global peers

Press/Media

Period13 Sep 2024

Media coverage

1

Media coverage

  • Title4D Molecular Therapeutics tumbles 21% in 2024, underperforming 87% of its global peers
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date13/09/24
    PersonsNancy Miller
View all 1
View less